United States · FDA National Drug Code directory
liothyronine sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62756-591_af12cd5c-3963-4ef2-b819-a42343f0cb69
- Product NDC
- 62756-591
- Form
- TABLET
- Composition / generic term
- liothyronine sodium
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191128
- Source listing expiry
- 20261231
Source-listed ingredients
- LIOTHYRONINE SODIUM — 50 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET in 1 BOTTLE (62756-591-01) · 62756-591-01
- 100 TABLET in 1 BOTTLE (62756-591-08) · 62756-591-08
- 1000 TABLET in 1 BOTTLE (62756-591-18) · 62756-591-18
- 30 TABLET in 1 BOTTLE (62756-591-83) · 62756-591-83
- 100 TABLET in 1 BOTTLE (62756-591-88) · 62756-591-88
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →